Renaissance Technologies
UROV

Renaissance Technologies’s Urovant Sciences Ltd. UROV Stock Holding History

Renaissance Technologies’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,500
Closed -$537K – 3853
2020
Q3 		$537K Sell
57,500
-51,828
-47% -$460K ﹤0.01% 2790
2020
Q2 		$1.08M Buy
+109,328
New +$1.05M ﹤0.01% 2502
2020
Q1 		– Sell
-12,300
Closed -$191K – 3968
2019
Q4 		$191K Buy
+12,300
New +$133K ﹤0.01% 3206

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
OCM
Orchard Capital Management Chicago, Illinois $95.9M AUM 45.49% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Renaissance Technologies's UROV Position: Q4 2020 in Review

Renaissance Technologies sold out of Urovant Sciences Ltd. (UROV) in Q4 2020, closing a stake of 57,500 shares — an estimated $537K sold.

Renaissance Technologies first reported a position in UROV in Q4 2019 and held it in 3 quarters. The position peaked at $1.08M in Q2 2020. 41 funds tracked by Wall St. Rank hold UROV as of Q4 2020.

  • Renaissance Technologies reported no remaining Urovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Renaissance Technologies sold 57,500 Urovant Sciences Ltd. shares in Q4 2020, an estimated $537K.
  • Renaissance Technologies first reported a position in Urovant Sciences Ltd. in Q4 2019 and held it in 3 quarters.
  • Renaissance Technologies's Urovant Sciences Ltd. position peaked at $1.08M in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q4 2020.

Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.